SCHEMBL20303552

SCHEMBL20303552

CCCC=C[C@H]1C(=O)CC[C@@H]1CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.54
AKR1C3 P42330 1/20 0.54
AKR1C2 P52895 1/20 0.54
HTT P42858 1/20 0.37
ALOX5 P09917 1/20 0.36
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 1/20 0.32
SLCO2A1 Q92959 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
PTGER2 P43116 4/20 0.31
SLC6A12 P48065 3/20 0.31
SLC6A11 P48066 3/20 0.31
SLC6A13 Q9NSD5 3/20 0.31
PTGER4 P35408 3/20 0.31
PTGER3 P43115 2/20 0.31
PTGIR P43119 2/20 0.30
NR1I2 O75469 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5598068 1.00 AKR1C4 (0.54) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL5598064 1.00 AKR1C4 (0.54) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL5383512 1.00 AKR1C4 (0.54) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL30307635 0.90 AKR1C4 (0.44) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL11840607 0.88 AKR1C4 (0.40) AKR1C4AKR1C3AKR1C2HTTTP53
SCHEMBL4399644 0.84 AKR1C4 (0.38) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL28790649 0.84 AKR1C4 (0.38) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL4399647 0.84 AKR1C4 (0.38) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL4399643 0.84 AKR1C4 (0.38) AKR1C4AKR1C3AKR1C2HTTALOX5
SCHEMBL25276408 0.83 HTT (0.46) AKR1C4AKR1C3AKR1C2HTTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11963531-B2 Microbial compositions and methods MONSANTO TECHNOLOGY LLC (US) 2024-04-23 US disclosed
WO-2024068519-A1 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 WO disclosed
WO-2024068518-A1 3-HETEROARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 WO disclosed
WO-2024068520-A1 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 WO disclosed
WO-2024068517-A1 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 WO disclosed
US-11917935-B2 Seed treater with baffles and method of treating seeds using same MONSANTO TECHNOLOGY LLC (US) 2024-03-05 US disclosed
US-20240057612-A1 Combinations of Yersinia Entomophaga and Pesticides or Other Substances NOVOZYMES BIOAG A/S (DK) 2024-02-22 US disclosed
EP-4295688-A1 ACTIVE COMPOUND COMBINATION Bayer Aktiengesellschaft (DE) 2023-12-27 EP disclosed
EP-3631019-B1 STABLE INOCULANT COMPOSITIONS COMPRISING PARAFFIN OILS/WAXES NOVOZYMES BIOAG AS (DK) 2023-10-11 EP disclosed
US-20230276808-A1 MICROBIAL COMPOSITIONS AND METHODS MONSANTO TECHNOLOGY LLC (US) 2023-09-07 US disclosed
WO-2019147660-A1 METHOD OF ENHANCING SEED GERMINATION UNDER ABIOTIC STRESS WITH CHITIN OLIGOSACCHARIDES NOVOZYMES BIOAG A/S (DK) 2019-08-01 WO disclosed
WO-2019136198-A1 AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES NOVOZYMES BIOAG A/S (DK) 2019-07-11 WO disclosed
EP-3462881-A1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME Novozymes BioAG A/S (DK) 2019-04-10 EP disclosed
US-20190029262-A1 Stable Inoculant Compositions and Methods for Producing Same NOVOZYMES BIOAG A/S (DK) 2019-01-31 US disclosed
US-20190014786-A1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME NOVOZYMES BIOAG A/S (DK) 2019-01-17 US disclosed
WO-2018218016-A1 STABLE INOCULANT COMPOSITIONS COMPRISING PARAFFIN OILS/WAXES NOVOZYMES BIOAG A/S (DK) 2018-11-29 WO disclosed
US-20180279624-A1 Stable Inoculant Compositions and Methods for Producing Same NOVOZYMES BIOAG A/S (DK) 2018-10-04 US disclosed
US-20180249705-A1 CONTAINERIZED LIQUID FORMULATIONS MONSANTO TECHNOLOGY LLC (US) 2018-09-06 US disclosed
US-20180201549-A1 USE OF FUNGAL STRAINS TO SOLUBILIZE PHOSPHATE AND ENHANCE PLANT GROWTH/YIELD NOVOZYMES BIOAG A/S (DK) 2018-07-19 US disclosed
WO-2018118740-A1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME NOVOZYMES BIOAG A/S (DK) 2018-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240057612-A1 Combinations of Yersinia Entomophaga and Pesticides or Other Substances TRHDE, MLNR, ZAP70 AKR1C4 3670/4885AKR1C3 3968/4885AKR1C2 3791/4885
US-20190029262-A1 Stable Inoculant Compositions and Methods for Producing Same MGAM, MGAM2, MRPL21 AKR1C4 1318/4885AKR1C3 1793/4885AKR1C2 1407/4885
US-20180279624-A1 Stable Inoculant Compositions and Methods for Producing Same SPOUT1, ERG28, EXOSC9 AKR1C4 1984/4885AKR1C3 2375/4885AKR1C2 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.